Article
A plant-derived flavonoid inhibits entry of all HCV genotypes into human hepatocytes.
Gastroenterology - 1 Jul 2012
Haid Sibylle, Novodomská Alexandra, Gentzsch Juliane, Grethe Christina, Geuenich Silvia, Bankwitz Dorothea, Chhatwal Patrick, Jannack Beate, Hennebelle Thierry, Bailleul Francois, Keppler Oliver T, Poenisch Marion, Bartenschlager Ralf, Hernandez Céline, Lemasson Matthieu, Rosenberg Arielle R, Wong-Staal Flossie, Davioud-Charvet Elisabeth, Pietschmann Thomas
Abstract excerpt
BACKGROUND & AIMS: Interferon-based therapies for hepatitis C virus (HCV) infection are limited by side effects and incomplete response rates, particularly among transplant recipients. We screened a library of plant-derived small molecules to identify HCV inhibitors with novel mechanisms. METHODS...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
